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Gang Li, Ming Li, Jing Wang, Fuquan Hu* and Shuai Le*
Department of Microbiology, Third Military Medical University, Chongqing, China
Capsaicin (CAP) reduces body weight mainly through activation of transient receptor
potential vanilloid 1 (TRPV1) cation channel. However, recent evidence indicates that
the gut microbiota influences many physiological processes in host and might provoke
obesity. This study determined whether the anti-obesity effect of CAP is related to the
changes in gut microbiota. C57BL/6 mice were fed either with high-fat diet (HFD) or
HFD with CAP (HFD-CAP) for 9 weeks. We observed a significantly reduced weight
gain and improved glucose tolerance in HFD-CAP-fed mice compared with HFD-fed
mice. 16S rRNA gene sequencing results showed a decrease of phylum Proteobacteria
in HFD-CAP-fed mice. In addition, HFD-CAP-fed mice showed a higher abundance
of Akkermansia muciniphila, a mucin-degrading bacterium with beneficial effects on
host metabolism. Further studies found that CAP directly up-regulates the expression of
Mucin 2 gene Muc2 and antimicrobial protein gene Reg3g in the intestine. These data
suggest that the anti-obesity effect of CAP is associated with a modest modulation of
the gut microbiota.
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INTRODUCTION
Obesity is a global health problem that increases the risk of many physical and mental conditions,
such as metabolic syndrome (Ogden et al., 2007). Diet regulation and exercise are the main
treatments to obesity. Several molecules from diet have been shown to reduce body weight. CAP
is an ingredient of chili peppers, which are consumed worldwide as vegetables and flavorings
(Yang et al., 2010). The anti-obesity effect of CAP has been extensively reported in both human
and animal studies (Derbenev and Zsombok, 2016), but the mechanisms are very complicated,
which include regulation of whole body metabolism or reduction of food intake. Ludy et al. (2012)
reported a modest correlation of CAP consumption and body weight reduction. CAP activates the
Abbreviations: ATCC, American type culture collection; AUC, area under the curve; CAP, capsaicin; GIP, gastric inhibitory
polypeptide; HFD, high-fat diet; KEGG, Kyoto Encyclopedia of Genes and Genomes; Klf4, Kruppel-like factor 4; Muc2, mucin
2 gene; NMDS, non-metric multi-dimensional scaling; OTU, operational taxonomic unit; PAS, Periodic Acid-Schiff; Reg3g,
regenerating islet-derived 3 gamma; TRPV1, transient receptor potential vanilloid 1.
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TRPV1 cation channel and enhances catecholamine secretion
from adrenal medulla to increase thermogenesis and to reduce
weight gain and adipogenesis (Kawabata et al., 2006; Hachiya
et al., 2007). CAP can also enhance thermogenesis by activating
gastrointestinal TRPV1 in mice (Kawabata et al., 2009). Lee
et al. (2015) found that CAP can reduce food intake, which is
dependent on TRPV1. The anti-obesity effect of CAP via TRPV1
activation has been extensively studied, but the impact of CAP on
gut microbiota has not been well studied.
Recently, growing evidences showed that dysbiosis of gut
microbiota plays a significant role in the development of
obesity and metabolic syndromes (Sonnenburg and Backhed,
2016; Wang and Jia, 2016). The gut microbiota has numerous
physiological and pathological interactions with the host, such
as host energy balance regulation, glucose metabolism, and the
chronic inflammatory state (Sonnenburg and Backhed, 2016).
Profound changes in the composition of the gut microbiota
have been uncovered in obese mice and humans. HFD increased
the levels of phyla Firmicutes and Proteobacteria and decreased
the abundance of Bifidobacterium spp. and Lactobacillus gasseri,
which are known to have beneficial effects on hosts (Wang and
Jia, 2016).
At the species level, the abundance of Akkermansia
muciniphila has been shown to inversely correlate with
obesity and type I diabetes in both mice and humans (Everard
et al., 2013; Shin et al., 2014; Dao et al., 2016). A. muciniphila
is a mucin-degrading bacterium that can use gastric mucin
as the sole carbon and nitrogen source (Derrien et al., 2004,
2011; Collado et al., 2007; Derrien, 2007; van Passel et al.,
2011). The oral administration of A. muciniphila prevents
HFD-induced obesity by altering adipose tissue metabolism
and gut barrier function (Everard et al., 2013). The anti-
obesity effect of a polyphenol-rich cranberry was associated
with increased Akkermansia spp. population in the mice gut
(Anhê et al., 2015). Therefore, these experiments showed that
gut microbiota dysbiosis may stimulate the development of
obesity and the modulation of gut microbiome may reduce
body weight (Derrien et al., 2016; Gomez-Gallego et al.,
2016).
Recently, Baboota et al. (2014) detected a significant gut
microbial alteration in CAP treated mice by qPCR, but the
detailed changes in microbiome are lacking. In this study, we
explored the effects of CAP on gut microbiota in HFD-fed mice
by high throughput sequencing and determined whether the anti-
obesity effect is related to the modulation of the gut microbiota.
MATERIALS AND METHODS
Animals and Diets
C57BL/6J male mice (Animal Center, Third Military Medical
University) were bred, no more than six mice per cage
in the animal facility of Third Military Medical University.
Animals were housed in a controlled environment (12 h
per day/night cycle and lights off at 19:00) with free access
to food and water. All animal protocols were approved by
the institute of Animal Care and Use Committee (Approval
number: SYXC-2014-00203). The animal experiments were
performed in accordance with the Guidelines for the Care
and Use of Laboratory Animals at Third Military Medical
University.
After 1 week of acclimation (week 0) on a normal chow diet, 5-
week-old mice (n = 12) were randomly divided into two groups
of six and fed the following diets (Luo et al., 2012): (1) a HFD
containing 45% fat and (2) a HFD with 0.01% CAP (a gift from
Prof. Zhiming Zhu, Daping Hospital, Third Military Medical
University) treatment in food (HFD-CAP). Animals were given
unrestricted access to food and water.
Body weight and average food intake were monitored every
day in the 1st week (week 1) after treatment and once a week
after week 1. During week 9, mice feces were collected and
stored at−80◦C until DNA extraction, and oral glucose tolerance
test (OGTT) was assessed. At last, animals were anesthetized
with amobarbital and then sacrificed by cardiac puncture. Gut
tissues were collected for histological staining or tissue RNA
extraction.
For RT-qPCR experiment, sixteen 6-week C57BL/6J male mice
were randomly divided into four groups and all were fed orally
with CAP (0.4 mg in 200 µL PBS and 0.4 mg is computed
according to the daily consumption of 4 g of chow per mice
multiplied by 0.01%), At the four time points (0, 30, 60, and
90 min), one group of mice (n = 4) were anesthetized with
amobarbital, and the jejunum and proximal colon tissue samples
were collected for RNA extraction.
Glucose Homeostasis
Mice were fasted overnight (17:00–9:00), and an OGTT was
performed after gavage with glucose (1 g/kg body weight, volume:
∼200 µL) (Anhê et al., 2015). Blood glucose concentrations were
measured with glucometer (Johnson, USA) before (0 min) and
after (15, 30, 60, 90, and 120 min) glucose challenge (Ayala et al.,
2010; Anhê et al., 2015).
Gut Microbiota Analysis
Fecal bacterial DNA was extracted using QIAamp DNA Stool
Mini Kit (QIAGEN, German) from approximately 100 mg
feces according to the manufacturer’s protocol. For each sample,
the V4 hypervariable region of the bacterial 16S rRNA gene
was amplified using primers 515F (5′-GTGCCAGCMGC
CGCGGTAA-3′) and 806R (5′-GGACTACHVGGGTWTCTAA
T-3′) (Caporaso et al., 2011), purified, and then sent to Novogene
Corporation for the generation of sequencing libraries by using
TruSeq DNA PCR-Free Sample Preparation Kit (Illumina, USA)
and sequenced on the Illumina Hiseq 2500 platform.
After de-multiplexing of the paired-end 250 bp raw reads,
Trimmomatic (v0.32) (Bolger et al., 2014) was used to clean
low-quality reads and remove adapter sequences. Paired ends
were merged using FLASH (v1.2.7) (Magoc and Salzberg, 2011)
and filtered under specific filtering conditions to obtain high-
quality clean tags according to the QIIME (v1.91) (Caporaso
et al., 2010) quality control process. The OTU picking processing
adopted an open-reference OTU picking protocol by searching
reads against the Greengenes (gg_13_8) (DeSantis et al., 2006)
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database (similarity ≥ 0.97) according the QIIME tutorial1 and
the diversity analyses followed the same tutorial. LEFSe (Version
1.0) (Segata et al., 2011) was used to discover the metagenomic
biomarker for both organisms and pathways. PICURSt (Version
1.0.0-dev) (Langille et al., 2013) and HUManN (Version 0.99)
(Abubucker et al., 2012) were used to predict functional profiling
of microbial communities using 16S rRNA amplicon sequencing
result following the PICURSt tutorial2,3.
Determination of absolute abundance of A. muciniphila
followed the method from Everard et al. (2013). Briefly,
A. muciniphila specific primers (forward: 5′-CAGCACGTGAAG
GTGGGGAC-3′, reverse: 5′-CCTTGCGGTTGGCTTCAGAT-
3′) were used to detect A. muciniphila through real time PCR.
A standard curve (performed in triplicate) was made by fivefold
serial dilutions of genomic DNA of A. muciniphila (ATCC BAA-
835). And the cycle threshold of each sample was compared with
the standard curve.
Bacterial Strains and Growth Curve
Akkermansia muciniphila strain ATCC BAA-835 was purchased
from the ATCC. Strains were cultured in BHI medium in tubes
at 37◦C in anaerobic chamber (Whitley A35 Workstation 2.5,
Don Whitley Scientific, UK). To acquire the growth curve of
A. muciniphila, 3 mL cell cultures were grown with different
concentrations (2, 20, and 200 µg/mL) of CAP or with equal
volume (2 µL for 1 mL medium) of ethanol. Mucin (from
porcine stomach, Type II, Sigma, USA, #SLBH5886V) was added
to the final concentration of 4 g/L when needed. CAP (Sigma,
USA, #MKBS2249V) was dissolved in ethanol. Cell density
was measured by serial 10-fold dilution and plating on BHI
agar plates (1% agar). Each experiment was repeated three
times.
Gene Expression
Total RNA was extracted from the jejunum and proximal
colon using TriPure (Roche, Switzerland). Genomic DNA
removal and cDNA synthesis were performed using TransScript
II One-Step gDNA Removal and cDNA Synthesis SuperMix
(Transgen, China). Real-time PCR was performed using SYBR
Premix Ex Taq II (Takara, Japan) with 1:5 diluted cDNA
products.
Target genes including Muc2 and Klf4 (a goblet cell marker),
and Reg3g (an antimicrobial marker), gene were detected with
hypoxanthine guanine phosphoribosyl transferase (Hprt) as the
housekeeping gene (Anhê et al., 2015). Data were calculated
according to the 2−11Ct method.
Goblet Cell Staining
The distal ileum and proximal colon were stained with PAS,
(Sigma, USA) as previously described (Shin et al., 2014). The
goblet cells were stained pink to red and nuclei were blue.
1http://nbviewer.jupyter.org/github/biocore/qiime/blob/1.9.1/examples/ipynb/
illumina_overview_tutorial.ipynb
2http://picrust.github.io/picrust/tutorials/metagenome_prediction.html
3http://picrust.github.io/picrust/tutorials/humann_tutorial.html
Statistical Analysis
Weight, glycemia, goblet cell count and gene expression level data
are expressed as mean ± SEM. For different abundance taxon
analyses in STAMP (Parks et al., 2014), Welch’s t-test was used
for the comparison of two groups. One way ANOVA followed by
Newman–Keuls post hoc was used for real time PCR results tests.
Student’s t-test was used for other cases.
RESULTS
Anti-obesity Effect of Capsaicin in Mice
Fed with High-Fat Diet
To assess the effect of CAP on obesity, 5-week-old male
C57BL/6 mice were fed either with HFD or HFD-CAP diet
for 9 weeks (Figure 1A). The HFD-CAP-fed mice had a lower
(P < 0.05) body weight gain (6.52 ± 0.45 g) than HFD-fed mice
(7.7 ± 1.29 g) (Figure 1B; Supplementary Figure S1A), which
was associated with reduction of food intake (Supplementary
Figure S1B). The sharp reduction of weight at week 1 could be
explained by the reduction of food intake during the early days
after suddenly change of food containing spicy CAP. Next, we
used a glucose tolerance test to examine glucose homeostasis
in CAP-treated and non-treated mice. Compared with HFD-fed
mice, HFD-CAP-fed mice showed a smaller (P < 0.05) AUC
(Figure 1C; Supplementary Figure S1C), which indicated an
improvement in glucose tolerance. These findings confirmed
that dietary CAP helped prevent obesity and improved glucose
homeostasis under HFD conditions.
Capsaicin Altered the Gut Microbiota
and Increased the Abundance of
Akkermansia
Fecal DNA of all the 12 mice at week 9 were extracted and
sequenced by 16S rRNA gene amplicons sequencing. The average
effective tags per sample were 54 thousand (ranging from 47
thousand to 63 thousand tags/sample).
The NMDS plot of the microbial compositions of the 12
samples revealed that the HFD and HFD-CAP group have similar
microbiome composition (Figure 2A). However, at the phylum
level, among the top 10 abundant phyla, the average proportion
of Acidobacteria, Bacteroidetes, and Firmicutes was increased in
HFD-CAP group, while the abundance level of Deferribacteres
and Proteobacteria was decreased (Figure 2B). According to
Welch’s t-tests by STAMP (Parks et al., 2014), only the decrease
(from 24.63 ± 4.18% to 16.92 ± 3.83%) of Proteobacteria
abundance is significant (P = 0.013) (Figure 2D).
At the genus level, among the top 10 abundant genera,
the average proportion of Helicobacter and Mucispirillum was
decreased in the HFD-CAP group (Figure 2C). According to
Welch’s t-tests by STAMP, the abundance levels of Bacteroides
(from 0.56 ± 0.35% to 1.55 ± 0.66%), Coprococcus (from
0.88% ± 0.32% to 1.60 ± 0.57%), Prevotella (from 1.58 ± 0.84%
to 3.07 ± 1.18%), and Akkermansia (from 0.03 ± 0.04%
to 0.12 ± 0.07%) increased significantly (Figure 2E). Real-
time PCR also confirmed the increase (p < 0.01) of absolute
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FIGURE 1 | (A) Groups information. Five-week-old male mice (n = 12) were randomly divided into two groups of six and fed the following diets: (1) a HFD containing
45% fat and (2) a HFD with 0.01% capsaicin treatment in food (HFD-CAP). (B) Gained body weight within 9 weeks. (C) Oral glucose tolerance test (OGTT) was
performed after gavage with glucose (1 g/kg body weight). Blood glucose concentrations were measured with glucometer before (0 min) and after (15, 30, 60, 90,
and 120 min) glucose challenge.
abundance of A. muciniphila (Figure 2F) in HFD-CAP
group.
We compared the fecal microbiota in HFD and HFD-CAP
groups using LEfSe (Segata et al., 2011) to identify the specific
bacterial taxa associated with treatment of CAP. A cladogram
representative of the structure of the fecal microbiota was
shown in Figure 3B. The greatest differences in multiple
levels of taxa between the two communities were displayed
(Figure 3A). These data indicated the significantly decreased
phylum Proteobacteria can be one of the biomarkers of HFD
group. Family Bacteroidaceae and its genus Bacteroides can be the
biomarkers of HFD-CAP group.
The changes in microbial taxa are associated with changes
in functional gene abundances, as predicted from 16S rRNA
data analysis using the PICRUSt (phylogenetic investigation of
communities by reconstruction of unobserved state) software
(Langille et al., 2013). LEFSe identified that three KEGG
pathways, including lysine degradation, Glutathione metabolism,
and Parkinsons disease, were enriched in HFD group, while
two pathways, including cyanoamino acid metabolism and
streptomycin biosynthesis, are enriched in HFD-CAP group
(Figure 4A). At the module level (Figure 4B), the type
IV secretion system modules and arginine/ornithine transport
system are enriched in HFD group. Glycolysis (Embden-
Meyerhof pathway), uridine monophosphate biosynthesis, and
aminoethyl phosphonate transport system are enriched in HFD-
CAP group.
Capsaicin Is Toxic to A. muciniphila, But
Mucin Promotes A. muciniphila Growth
In vitro
To test whether CAP directly stimulated the growth of
A. muciniphila in vitro, the growth curve of A. muciniphila strain
ATCC BAA-835 was monitored in both BHI medium and BHI
medium with mucin (from porcine stomach, Type II) (Figure 5).
Frontiers in Microbiology | www.frontiersin.org 4 February 2017 | Volume 8 | Article 272
fmicb-08-00272 February 22, 2017 Time: 16:19 # 5
Shen et al. Capsaicin Treatment Changes Gut Microbiota
FIGURE 2 | Microbiome composition. (A) NMDS for ordination plot of normalized counts at the OTU level (stress = 0.048). (B,C) Taxonomy composition at the
phylum and genus levels. The top 10 phyla/genera were reported for each group, and all others are grouped into “others.” (D,E) Taxa that differ significantly between
HFD-CAP and HFD at the phylum and genus level. (F) Absolute abundance of Akkermansia muciniphila in fecal content by qPCR. ∗∗P < 0.01.
High concentration of CAP (20 or 200 µg/mL) inhibited the
growth of A. muciniphila, whereas low concentration of CAP
(2 µg/mL) did not promote the growth of A. muciniphila
in vitro directly (Figures 5A,B). However, the addition of
mucin directly promoted the growth of A. muciniphila in
BHI medium (Figures 5B,C). When mucin was provided,
A. muciniphila grew faster at log phase and plateaued at a much
higher cell density. Thus, mucin could promote A. muciniphila
growth.
Capsaicin Increases Muc2 and Reg3g
Gene Expression in the Intestine
The addition of mucin directly stimulated A. muciniphila growth,
and mucin is secreted by goblet cells in vivo. Thus, we examined
the number of goblet cells in jejunum and colon in HFD and
HFD-CAP mice at week 9. PAS staining was used to stain goblet
cells (Figures 6A,B), and PAS-positive goblet cells per villus were
counted. An average of 13 goblet cells was seen in HFD-CAP
mice, which did not show a significant difference from that in
HFD mice (Figure 6C).
To further explore the effect of CAP on goblet cells, sixteen
6-week C57BL/6J male mice were randomly divided into four
groups (n= 4) and all were fed orally with CAP (0.4 mg in 200 µL
PBS, see Materials and Methods). Gene expressions at four time
points (0, 30, 60, and 90 min) in jejunum and proximal colon
tissue samples were detected by qPCR. We tested the Klf4 gene, a
marker of goblet cells that regulated goblet cells’ differentiation.
CAP did not directly increase Klf4 mRNA expression in jejunum
or colon within 90 min after the oral administration of CAP
(Figure 6D).
We next examined the expression of the major goblet cell
mucin production gene (Muc2) after CAP treatment. Mucin
2 mRNA expression was increased twofold at 30 min after
CAP administration and lasted for 1.5 h in the jejunum
(P < 0.05).
Last, we measured the mRNA expression of Reg3g, an
antimicrobial protein that is predominantly expressed in
the gastrointestinal tract (Wang et al., 2016). Reg3g has
bactericidal activity and restricts bacterial colonization of
mucosal surfaces. As is shown in Figure 6D, according
the mean expression abundance values, Reg3g mRNA
expression is steadily up-regulated in the colon after
CAP administration and increased to about threefold
at 90 min. However, the differences were not statistically
significant.
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FIGURE 3 | LEfSe identified the most differentially abundant taxa at the genus level between HFD-CAP and HFD group. (A) HFD-CAP-enriched taxa are
indicated with a positive LDA score (green) and taxa enriched in HFD with a negative score (red). Only taxa meeting an LDA significant threshold of >2 are shown.
(B) Taxonomic cladogram obtained from LEfSe analysis of 16S sequences HFD-enriched taxa (Red); taxa enriched in HFD-CAP (Green). The brightness of each dot
is proportional to its effect size. Each circle’s diameter is proportional to the taxon’s abundance.
FIGURE 4 | LEfSe identified the most differentially abundant PICRUSt-predicated KEGG pathway between HFD-CAP and HFD group.
HFD_CAP-enriched pathway (A) and module (B) are indicated with a positive LDA score (green), and pathway (A) and module (B) enriched in HFD with a negative
score (red). Only taxa meeting an LDA significant threshold of >2 are shown.
DISCUSSION
Capsaicin is a worldwide consumed ingredient from chili
peppers, and its anti-obesity function has been extensively
studied through activation of TRPV1 channel (Yang et al., 2010;
Ludy et al., 2012). Here, we found that the beneficial effects
of CAP treatment on reducing body weight were associated
with a modest modulation of gut microbiota. At the genus
level, the proportion of Bacteroides, Coprococcus, Prevotella, and
Akkermansia increased significantly. Recent studies indicated
that obese individuals are associated with less Bacteroides (Qin
et al., 2012; Johansson et al., 2013; Sonnenburg and Backhed,
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FIGURE 5 | Growth curves of Akkermansia muciniphila in different conditions. A. muciniphila strain ATCC BAA-835 was cultured in BHI (A) or BHI+Mucin (B)
medium with different concentrations (2, 20, and 200 µg/mL) of CAP (dissolved in ethanol) or with equal volume (2 µL for 1 mL medium) of ethanol. (C) Growth
curves of A. muciniphila in BHI and BHI+Mucin medium without CAP or ethanol.
FIGURE 6 | (A,B) Representative red photomicrographs showing ileal section stained with periodic acid-Schiff (PAS), and goblet cells were stained pink to red and
nuclei were blue. (C) Count number of PAS-positive goblet cells per villus. (D) Gene expression level of Klf4, Muc2, and Reg3g (n = 4). ∗P < 0.05.
Frontiers in Microbiology | www.frontiersin.org 7 February 2017 | Volume 8 | Article 272
fmicb-08-00272 February 22, 2017 Time: 16:19 # 8
Shen et al. Capsaicin Treatment Changes Gut Microbiota
2016; Wang and Jia, 2016), and the increased abundance of
Bacteroides may be beneficial to the health. Genus Coprococcus
was reported to be positively correlated with the GIP, (which
is also known as glucose-dependent insulinotropic peptide) that
induces insulin secretion (Thorens, 1995). Thus, the increase of
Coprococcus might contribute to the improvement of glucose
tolerance.
We observed an increase in the relative abundance of
A. muciniphila at HFD-CAP mice. Recently, Baboota et al.
(2014) used qPCR to detect the changes of seven gut microbes
in HFD-CAP fed mice and found that the relative abundance
of A. muciniphila increased. Interestingly, an increase of
Akkermansia has also been reported in other microbiome studies.
Anhê et al. (2015) found that a polyphenol-rich cranberry extract
increased the relative abundance of Akkermansia, and the author
claimed that the increase in Akkermansia population might
prevent the production of the negative metabolic phenotype
that is associated with obesity. Greer et al. (2016) found that
A. muciniphila mediates negative effects of IFNγ on glucose
metabolism. Kemperman et al. (2013) reported that complex
polyphenols from black tea modulated the human gut microbial
ecosystem, with an increase of Akkermansia. Roopchand et al.
(2015) showed that dietary polyphenols promoted the growth of
A. muciniphila and attenuate HFD-induced metabolic syndrome
(Roopchand et al., 2015). Moreover, the antidiabetic drug
metformin also has been found to modulate the gut microbiome
and lined with an increased abundance of this bacterium
(Shin et al., 2014). All these studies pointed out that a better
health condition by dietary or pharmaceutical interventions is
associated with increased A. muciniphila.
The probiotic effects of A. muciniphila have been studied
extensively in animals and clinical studies, and the potential
mechanisms were reported from cell biology studies (Derrien
et al., 2011; Everard et al., 2013; Lukovac et al., 2014; Li et al.,
2016). Therefore, we infer that the alteration of gut microbiota
and increased A. muciniphila might contribute to the anti-obesity
effects of CAP.
However, the mechanisms by which dietary or pharmaceutical
interventions, including CAP, reshaped the gut microbiota and
increased the relative abundance of A. muciniphila are still not
unclear. Among all the current studies, the mechanism that
directly stimulates the growth of A. muciniphila in vivo is lacking
and a proposed mechanism is increased mucus production.
We found that CAP inhibits the growth of A. muciniphila in
high concentration and did not promote its growth at lower
concentrations (Figures 5A,B). Since A. muciniphila is a mucin-
degrading bacterium, A. muciniphila grows faster and plateaued
at a higher cell density with the addition of mucin in the culture
medium (Figure 5C). This result is consistent with previous
reports (Derrien et al., 2004). Van den Abbeele et al. (2011)
also showed that the abundance of A. muciniphila is positively
correlated with the levels of mucins in the cecum. Therefore, we
infer that CAP might stimulate mucin secretion in the gut to
promote A. muciniphila growth.
Mucin is secreted by goblet cell, but we did not found a
significant increase of goblet cell numbers in the colon after
9 weeks of CAP intervention, and CAP did not directly stimulate
the expression of Kruppel-like factor (Klf4), the key factor that
regulates goblet cell differentiation, in 90 min. However, an
increased Muc2 mRNA expression in the colon was observed
after CAP treatment for 30 min. Interestingly, Karmouty-
Quintana et al. (2007) showed that CAP administration induces
mucus secretion in rat airways through the activation of sensory
nerves. Therefore, we infer that CAP might stimulate mucin
production and promote the growth of A. muciniphila in vivo,
though the molecular mechanism needs further investigation.
More interestingly, we observed a steady increase of
antimicrobial peptide Reg3g mRNA expression after CAP
intervention. Antimicrobial peptides are produced and secreted
by intestinal epithelial cells or Paneth cells and play a key
role in maintaining the homeostasis in gut microbiota (Bevins
and Salzman, 2011). Reg3g has bactericidal activity and keeps
gut bacteria from the intestinal epithelial surface (Wang
et al., 2016). Therefore, CAP might induce the antimicrobial
defense to modulate the gut microbial composition. Further
investigations are needed to better understand how CAP regulate
gut microbiome and stimulate A. muciniphila.
Another potential explanation for the relative increase of
A. muciniphila could be a decreased food intake in HFD-CAP fed
mice. We observed a reduced food intake in HFD-CAP fed mice
(Supplementary Figure S1B), which is consistent with previous
studies (Cui and Himms-Hagen, 1992). Contrary to many other
species, A. muciniphila can survive when host mucin is the only
carbon and nitrogen source (Derrien et al., 2004, 2011), while
most other microbes are dependent on food intake. Recently,
Holmes et al. (2017) found that a reduced nutrient intake is
associated with an increase in the abundance of Akkermansia.
Thus, the decreased food intake might result in a higher relative
abundance of A. muciniphila (Figures 2E,F).
CONCLUSION
In summary, we found that CAP treatment reduces body weight
and improves glucose homeostasis in HFD mice. This effect was
associated with a modest modulation of gut microbiome. The
changes in the gut microbiome and the increase in Akkermansia
population might play a key role in this protective effect. Thus,
we propose that CAP may prevent obesity through modulation
of the gut microbiota.
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